
CAS 1418205-77-2
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Bimekizumab
CAS :Humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody; plaque psoriasis and psoriatic arthritis treatment
Bimekizumab
CAS :Bimekizumab is a humanised monoclonal antibody targeting IL17A/IL17F, blocking inflammation-driven osteoblast differentiation.Degré de pureté :>99.99%Couleur et forme :LiquidMasse moléculaire :147.24 kDa


